Trimetazidine DiHCl - CAS 13171-25-0
Catalog: |
BB007473 |
Product Name: |
Trimetazidine DiHCl |
CAS: |
13171-25-0 |
Synonyms: |
1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride |
Application: |
Trimetazidine dihydrochloride could reduce fatty acid β-oxidation and used as a coronary vasodilator. |
Related CAS: | 5011-34-8 (free base)
|
IUPAC Name: | 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride |
Description: | Trimetazidine dihydrochloride, a piperazine derivative, could reduce fatty acid β-oxidation and used as a coronary vasodilator. |
Molecular Weight: | 339.26 |
Molecular Formula: | C14H22N2O3 · 2HCl |
Canonical SMILES: | COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC.Cl.Cl |
InChI: | InChI=1S/C14H22N2O3.2ClH/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16;;/h4-5,15H,6-10H2,1-3H3;2*1H |
InChI Key: | VYFLPFGUVGMBEP-UHFFFAOYSA-N |
Boiling Point: | 364 °C at 760 mmHg |
Melting Point: | 231-235 °C |
Purity: | 95 % |
Solubility: | 10 mM in H2O |
Appearance: | Crystalline solid |
Storage: | -20 °C Freeze |
MDL: | MFCD00243086 |
LogP: | 2.98830 |
GHS Hazard Statement: | H302 (98.17%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-110623934-A | Trimetazidine hydrochloride sustained release tablet and preparation method thereof | 20190926 |
KR-102255957-B1 | Novel dibenzooxaphosphinine oxide derivative compounds and pharmaceutical composition for preventing or treating degenerative disease comprising the same as an active ingredient | 20190909 |
KR-20210029993-A | Novel dibenzooxaphosphinine oxide derivative compounds and pharmaceutical composition for preventing or treating degenerative disease comprising the same as an active ingredient | 20190909 |
US-2020261443-A1 | Use of Anti-Ischemic Compounds in Treating Acute-On-Chronic Liver Failure | 20190215 |
CN-109580836-A | A kind of lomerizine hydrochloride raw material and detection method of the preparation in relation to substance | 20181231 |
PMID | Publication Date | Title | Journal |
33704910 | 20210601 | Trimetazidine improved adriamycin-induced cardiomyopathy by downregulating TNF-α, BAX, and VEGF immunoexpression via an antioxidant mechanism | Environmental toxicology |
25937560 | 20150705 | Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis | Chemico-biological interactions |
22162540 | 20121001 | Food effect on bioavailability of modified-release trimetazidine tablets | Journal of clinical pharmacology |
22536918 | 20120801 | Effects of sheath injury and trimetazidine on endothelial dysfunction of radial artery after transradial catheterization | Journal of interventional cardiology |
22790403 | 20120801 | Trimetazidine and inflammatory response in coronary artery bypass grafting | Arquivos brasileiros de cardiologia |
Complexity: | 259 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 3 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 338.1163980 |
Formal Charge: | 0 |
Heavy Atom Count: | 21 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 338.1163980 |
Rotatable Bond Count: | 5 |
Topological Polar Surface Area: | 43 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS